Clinical Trial Update: A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer [Phase 4]

View source ↗

Summary

Phase 4 safety study enrolling Indian adults with metastatic urothelial carcinoma to evaluate Enfortumab Vedotin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Enfortumab Vedotin (Padcev) (enfortumab vedotin)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Metastatic Urothelial Carcinoma | Phase 4 | Status: RECRUITING